论文部分内容阅读
目的:分析探索曲美他嗪联合丹红注射液治疗冠心病心绞痛的疗效。方法:研究对象:我院81例冠心病心绞痛患者。81例患者分为组一和组二2组。比较指标:(1)总有效率;(2)治疗前后患者心脏指数(CI)、左室射血分数(LVEF)、每博输出量(SV)、E峰加速时间、的差异。结果:跟组一比较,(1)组二总有效率更高,X~2检验P<0.05,有统计学意义;治疗后组二CI、LVEF、SV、E峰加速时间更佳,t检验P<0.05,有统计学意义。结论:曲美他嗪联合丹红注射液治疗冠心病心绞痛的疗效确切,可有效改善患者心功能,值得推广。
Objective: To analyze the effect of trimetazidine combined with Danhong injection in treating angina pectoris of coronary heart disease. Methods: Subjects: 81 patients with angina pectoris in our hospital. Eighty-one patients were divided into two groups. Comparison of the indicators: (1) the total effective rate; (2) before and after treatment in patients with cardiac index (CI), left ventricular ejection fraction (LVEF), the output per pulse (SV), E peak acceleration time difference. Results: Compared with group one, (1) the total effective rate of group two was higher, the X ~ 2 test P <0.05, with statistical significance; two groups after treatment, CI, LVEF, SV, E peak acceleration time is better, t test P <0.05, with statistical significance. Conclusion: Trimetazidine combined with Danhong injection is effective in treating angina pectoris of coronary heart disease, which can effectively improve the cardiac function of patients and is worth promoting.